2008
DOI: 10.1016/j.gie.2007.12.063
|View full text |Cite
|
Sign up to set email alerts
|

Intraductal US in the assessment of tumor involvement to the orifice of the cystic duct by malignant biliary obstruction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
15
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
5
1

Relationship

4
2

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 20 publications
2
15
0
Order By: Relevance
“…Tumor involvement at the orifice of the CD, as in our case, is a risk factor for cholecystitis [2,3] . In patients in whom the cholecystitis does not resolve with conservative therapy, percutaneous cholecystostomy may be necessary [3] .…”
Section: Discussionsupporting
confidence: 53%
See 1 more Smart Citation
“…Tumor involvement at the orifice of the CD, as in our case, is a risk factor for cholecystitis [2,3] . In patients in whom the cholecystitis does not resolve with conservative therapy, percutaneous cholecystostomy may be necessary [3] .…”
Section: Discussionsupporting
confidence: 53%
“…There is, however, a need to prevent and manage stent-related complications. Acute cholecystitis after SEMS placement is a serious complication, and tumor involvement at the orifice of the cystic duct (CD) is a risk factor [2,3] . Some patients with cholecystitis improve with conservative therapy, while others require percutaneous drainage.…”
Section: Introductionmentioning
confidence: 99%
“…Cholangitis without stent occlusion developed in one patient (number 7) and was treated with antibiotics. Acute cholecystitis developed in one patient (number 1) with tumor involvement at the orifice of the cystic duct [8,9] and was treated by percutaneous cholecystostomy. According to the Kaplan-Meier analysis, the median stent patency period was 202 days (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Before ComVi stent insertion, endoscopic sphincterotomy was performed. Tumor involvement at the orifice of the cystic duct (OCD), considered a risk factor of cholecystitis after metallic stent placement [10,13], was evaluated using cholangiography and intrabile duct ultrasonography with a microprobe [14] before insertion of the ComVi stent.…”
Section: Methodsmentioning
confidence: 99%